 |
|
Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial
Sun Young Yim, Sung Hwan Lee, Seung-Woo Baek, Bohwa Sohn, Yun Seong Jeong, Sang-Hee Kang, Kena Park, Hyewon Park, Sunyoung S. Lee, Ahmed O. Kaseb, Young Nyun Park, Sun-Hee Leem, Michael A. Curran, Ji Hoon Kim, Ju-Seog Lee
Clin Mol Hepatol. 2024;30(4):807-823. Published online 2024 Jul 23 DOI: https://doi.org/10.3350/cmh.2024.0333
|
|
Citations to this article as recorded by
 Targeting TIME in advanced hepatocellular carcinoma: Mechanisms of drug resistance and treatment strategies
Xinyi Ye, Xizhu Fang, Fangfang Li, Dan Jin
Critical Reviews in Oncology/Hematology.2025; 211: 104735. CrossRef Differential Infiltration of T-Cell Populations in Tumor and Liver Tissues Predicts Recurrence-Free Survival in Surgically Resected Hepatocellular Carcinoma
Eun Ji Jang, Ho Joong Choi, Young Kyoung You, Deok Hwa Seo, Mi Hyun Kwon, Keungmo Yang, Jaejun Lee, Jeong Won Jang, Seung Kew Yoon, Ji Won Han, Pil Soo Sung
Cancers.2025; 17(9): 1548. CrossRef Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
Meiyin Zhang, Chaojun Liu, Jing Tu, Min Tang, Milad Ashrafizadeh, Noushin Nabavi, Gautam Sethi, Peiqing Zhao, Shijian Liu
Molecular Cancer.2025;[Epub] CrossRef Management and Outcomes of Adverse Events Following Immune Checkpoint Inhibitor Treatment in Patients with Hepatocellular Carcinoma
Soon Kyu Lee, Bo Hyun Kim
Journal of Digestive Cancer Research.2025; 13(1): 65. CrossRef An Early Increase in IL-10 and TNF-α Levels Following Atezolizumab Plus Bevacizumab Treatment Predicts Survival in Advanced Hepatocellular Carcinoma Patients: A Prospective Cohort Study
Soon Kyu Lee, Soon Woo Nam, Ji Won Han, Jung Hyun Kwon
Cancers.2024; 16(20): 3543. CrossRef From biomarker discovery to combined therapies: Advancing hepatocellular carcinoma treatment strategies
Mo-Wei Kong, Yang Yu, Ying Wan, Yu Gao, Chun-Xiang Zhang
World Journal of Gastrointestinal Oncology.2024; 16(11): 4518. CrossRef
|